Physician profile
Larry L Erickson
NPI 1437195674
$382.13
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $168 · 2020: $82.68 · 2021: $131.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $208.55 | 2019-2021 | |
| Mylan Pharmaceuticals INC. | $24.14 | 2021 | |
| Amag Pharmaceuticals, INC. | $21.54 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.55 | 2019 | |
| Olympus America INC. | $19.54 | 2020 | |
| Hologic Sales and Service, LLC | $17.77 | 2019 | |
| Avanos Medical | $17.47 | 2019 | |
| Therapeuticsmd, INC. | $15.27 | 2019 | |
| Aspira Women'S Health INC | $15.05 | 2019 | |
| Merck Sharp & Dohme LLC | $12.20 | 2019 | |
| Avion Pharmaceuticals | $11.05 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larry Erickson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.